AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
-1.59%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.07B
AUM Growth
-$328M
(-7.5%)
Cap. Flow
+$67.8M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
46.29%
Holding
163
New
17
Increased
15
Reduced
14
Closed
15
Top Buys
| 1 |
Erasca
ERAS
|
$67.3M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$63.7M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$61.9M |
| 4 |
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
|
$42.9M |
| 5 |
Cytokinetics
CYTK
|
$28.6M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$72.6M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$68.8M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$38.8M |
| 4 |
Seer Inc
SEER
|
$28.9M |
| 5 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$24.3M |
Sector Composition
| 1 | Healthcare | 90.53% |
| 2 | Consumer Discretionary | 7.15% |
| 3 | Consumer Staples | 0.56% |
| 4 | Materials | 0.44% |
| 5 | Financials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Lifestance Health
LFST
$2.09B
| – | – |
-500,000
| Closed | -$13.9M |
|
152
Lufax Holding
LU
$2.6B
| – | – |
-12,500
| Closed | -$565K |
|
153
Seres Therapeutics
MCRB
$171M
| – | – |
-10,000
| Closed | -$4.77M |
|
|
MOLN
154
Molecular Partners
MOLN
$138M
| – | – |
-100,000
| Closed | -$2.05M |
|
155
Merck
MRK
$211B
| – | – |
0
| – | – |
|
|
PARA
156
DELISTED
Paramount Global Class B
PARA
| – | – |
-75,000
| Closed | -$3.39M |
|
157
Vertex Pharmaceuticals
VRTX
$101B
| – | – |
0
| – | – |
|
158
NeueHealth
NEUE
$60.3M
| – | – |
-3,819
| Closed | -$5.24M |
|
|
TRIL
159
DELISTED
Trillium Therapeutics Inc.
TRIL
| – | – |
-2,500,000
| Closed | -$24.3M |
|
|
TBIO
160
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| – | – |
-500,000
| Closed | -$13.8M |
|
|
CEREW
161
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
| – | – |
-79,600
| Closed | -$1.15M |
|
|
CHMA
162
DELISTED
Chiasma, Inc. Common Stock
CHMA
| – | – |
-380,000
| Closed | -$1.8M |
|
|
BHVN
163
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-400,000
| Closed | -$38.8M |
|